Advanced search
Publication Cover
Autoimmunity Volume 43, 2010 - Issue 5-6
Submit an article Journal homepage
427
Views
28
CrossRef citations to date
0
Altmetric
Research Article

Development of novel therapies for MG: Studies in animal models

M. C. SouroujonCorrespondence[email protected]
,
T. Brenner Department of Neurology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
&
S. Fuchs Department of Immunology, The Weizmann Institute of Science, Rehovot, 76100, Israel
Pages 446-460 | Received 26 Nov 2009, Accepted 30 Nov 2009, Published online: 19 Mar 2010

Citations (28)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (8)

Marinos C Dalakas. (2022) Role of complement, anti-complement therapeutics, and other targeted immunotherapies in myasthenia gravis. Expert Review of Clinical Immunology 18:7, pages 691-701.
Read now
Lorenzo Maggi, Fulvio Baggi & Renato Mantegazza. (2013) Orphan drugs to treat myasthenia gravis. Expert Opinion on Orphan Drugs 1:5, pages 373-384.
Read now
Jordi Díaz-Manera, Ricard Rojas García & Isabel Illa. (2012) Treatment strategies for myasthenia gravis: an update. Expert Opinion on Pharmacotherapy 13:13, pages 1873-1883.
Read now
Sivakumar Sathasivam. (2011) Current and emerging treatments for the management of myasthenia gravis. Therapeutics and Clinical Risk Management 7, pages 313-323.
Read now
Renato Mantegazza, Silvia Bonanno, Giorgia Camera & Carlo Antozzi. (2011) Current and emerging therapies for the treatment of myasthenia gravis. Neuropsychiatric Disease and Treatment 7, pages 151-160.
Read now
Marc H. De Baets. (2010) Insights in the autoimmunity of myasthenia gravis. Autoimmunity 43:5-6, pages 341-343.
Read now
Alejandro M. Gomez, Joost Van Den Broeck, Kathleen Vrolix, Sofie P. Janssen, Marijke A. M. Lemmens, Eline Van Der Esch, Hans Duimel, Peter Frederik, Peter C. Molenaar, Pilar Martínez-Martínez, Marc H. De Baets & Mario Losen. (2010) Antibody effector mechanisms in myasthenia gravis—Pathogenesis at the neuromuscular junction. Autoimmunity 43:5-6, pages 353-370.
Read now
Donald B. Sanders & Amelia Evoli. (2010) Immunosuppressive therapies in myasthenia gravis. Autoimmunity 43:5-6, pages 428-435.
Read now

Articles from other publishers (20)

Gianmaria Lorenzo Odierna & William Donald Phillips. (2021) The Safety Factor for Neuromuscular Transmission: Effects of Dimethylsulphoxide, Cannabinoids and Synaptic Homeostasis. Journal of Neuromuscular Diseases 8:5, pages 831-844.
Crossref
Marinos C. Dalakas, Harry Alexopoulos & Peter J. Spaeth. (2020) Complement in neurological disorders and emerging complement-targeted therapeutics. Nature Reviews Neurology 16:11, pages 601-617.
Crossref
Angela Lopomo & Sonia Berrih-Aknin. (2017) Autoimmune Thyroiditis and Myasthenia Gravis. Frontiers in Endocrinology 8.
Crossref
Sonia Berrih-Aknin. (2016) Role of the thymus in autoimmune myasthenia gravis. Clinical and Experimental Neuroimmunology 7:3, pages 226-237.
Crossref
Revital Aricha, Debby Reuveni, Sara Fuchs & Miriam C. Souroujon. (2016) Suppression of experimental autoimmune myasthenia gravis by autologous T regulatory cells. Journal of Autoimmunity 67, pages 57-64.
Crossref
Inga Koneczny, Pilar Martinez Martinez & Marc De Baets. 2016. Encyclopedia of Immunobiology. Encyclopedia of Immunobiology 168 179 .
Linda L. Kusner & Henry J. Kaminski. (2015) Editorial: Special issue on standardization of preclinical evaluation of animal models for myasthenia gravis. Experimental Neurology 270, pages 1-2.
Crossref
Sara Fuchs, Revital Aricha, Debby Reuveni & Miriam C. Souroujon. (2014) Experimental Autoimmune Myasthenia Gravis (EAMG): From immunochemical characterization to therapeutic approaches. Journal of Autoimmunity 54, pages 51-59.
Crossref
Pilar Martinez-Martinez, Peter C. Molenaar, Mario Losen & Marc H. de Baets. (2014) Glycine receptor antibodies in PERM: a new channelopathy. Brain 137:8, pages 2115-2116.
Crossref
Devorah Gur-Wahnon, Tehila Mizrachi, Shane Wald-Altman, Abd Al-Roof Higazi & Talma Brenner. (2014) Tissue plasminogen activator involvement in experimental autoimmune myasthenia gravis: Aggravation and therapeutic potential. Journal of Autoimmunity 52, pages 36-43.
Crossref
Smadar Gertel-Lapter, Keren Mizrachi, Sonia Berrih-Aknin, Sara Fuchs & Miriam C. Souroujon. (2013) Impairment of regulatory T cells in myasthenia gravis: Studies in an experimental model. Autoimmunity Reviews 12:9, pages 894-903.
Crossref
Roberta Marolda, Chiara Ruocco, Chiara Cordiglieri, Chiara Toscani, Carlo Antozzi, Renato Mantegazza & Fulvio Baggi. (2013) Differential targeting of immune-cells by Pixantrone in experimental myasthenia gravis. Journal of Neuroimmunology 258:1-2, pages 41-50.
Crossref
Weifan Yin, Windy Allman, Song Ouyang, Yi Li, Jing Li, Premkumar Christadoss & Huan Yang. (2013) The increased expression of CD21 on AchR specified B cells in patients with myasthenia gravis. Journal of Neuroimmunology 256:1-2, pages 49-54.
Crossref
Linda L. Kusner, Jose A. Halperin & Henry J. Kaminski. (2012) Cell surface complement regulators moderate experimental myasthenia gravis pathology. Muscle & Nerve 47:1, pages 33-40.
Crossref
Miriam C. Souroujon, Revital Aricha, Tali Feferman, Keren Mizrachi, Debby Reuveni & Sara Fuchs. (2012) Regulatory T cell-based immunotherapies in experimental autoimmune myasthenia gravis. Annals of the New York Academy of Sciences 1274:1, pages 120-126.
Crossref
Edna Blotnick, Yasmine Hamra‐Amitai, Chen Wald, Talma Brenner & Lili Anglister. (2012) Changes in acetylcholinesterase in experimental autoimmune myasthenia gravis and in response to treatment with a specific antisense. European Journal of Neuroscience 36:8, pages 3077-3085.
Crossref
Jindrich Soltys, Jose A. Halperin & Qin Xuebin. (2012) DAF/CD55 and Protectin/CD59 modulate adaptive immunity and disease outcome in experimental autoimmune myasthenia gravis. Journal of Neuroimmunology 244:1-2, pages 63-69.
Crossref
E. Steve Woodle, Rita R. Alloway & Alin Girnita. (2011) Proteasome inhibitor treatment of antibody-mediated allograft rejection. Current Opinion in Organ Transplantation 16:4, pages 434-438.
Crossref
Cary Hsu, Francisco Vega, Lynn M. Grimes & Kelly K. Hunt. (2011) Follicular Dendritic Cell Sarcoma and Associated Myasthenia Gravis: True,True, Related?. Journal of Clinical Oncology 29:13, pages e369-e371.
Crossref
Alejandro M. Gomez, Kathleen Vrolix, Pilar Martínez-Martínez, Peter C. Molenaar, Marko Phernambucq, Eline van der Esch, Hans Duimel, Fons Verheyen, Reinhard E. Voll, Rudolf A. Manz, Marc H. De Baets & Mario Losen. (2011) Proteasome Inhibition with Bortezomib Depletes Plasma Cells and Autoantibodies in Experimental Autoimmune Myasthenia Gravis. The Journal of Immunology 186:4, pages 2503-2513.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.